The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) which was developed by the Defence Research and Development Organisation (DRDO) in partnership with Dr Reddy’s Laboratories (DRL), Hyderabad, was released on Monday for emergency use. An anti-COVID-19 therapeutic application of the drug 2-DG has been developed by the Institute of Nuclear Medicine and Allied…
The Government has been constantly urging the citizens to get vaccinated against Covid-19 as it will help in immunizing the population and curbing the spread of the virus. The extent of the spread of the pandemic and the number of mortalities are at an all-time high in India. Therefore, the Centre on Friday released a…
All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria issued a warning on Monday and expressed concern over the fact that the people of India are failing to follow Covid-19 protocols due to which the current situation is spiralling out of control. He said that the new variant of the virus is highly…